Published in Pharmazie on November 01, 1999
Ester prodrug-loaded electrospun cellulose acetate fiber mats as transdermal drug delivery systems. J Mater Sci Mater Med (2010) 0.75
The optics of vitreous surgery. Am J Ophthalmol (1981) 2.67
Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia (2011) 1.44
Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol (2001) 1.42
Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol (2007) 1.34
Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci (2000) 1.30
Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release (1999) 1.27
Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol (1993) 1.15
Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm (2007) 1.09
"With the rule" astigmatism is not the rule in the elderly. Reykjavik Eye Study: a population based study of refraction and visual acuity in citizens of Reykjavik 50 years and older. Iceland-Japan Co-Working Study Groups. Acta Ophthalmol Scand (2000) 1.01
Retinal blood flow in normal and diabetic dogs. Invest Ophthalmol Vis Sci (1987) 1.00
Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate. Pharm Res (1992) 0.97
Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm (2001) 0.97
Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol (1986) 0.95
Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol (Copenh) (1994) 0.95
Screening for diabetic retinopathy. Initiation and frequency. Acta Ophthalmol Scand (1995) 0.94
Optic nerve oxygen tension: effects of intraocular pressure and dorzolamide. Br J Ophthalmol (2000) 0.93
Central retinal artery occlusion during cardiac catheterization. Am J Ophthalmol (1985) 0.92
Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Pharmazie (2001) 0.92
Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol (1997) 0.92
Systematic screening for diabetic eye disease in insulin dependent diabetes. Acta Ophthalmol (Copenh) (1994) 0.91
Dorzolamide-timolol combination and retinal vessel oxygen saturation in patients with glaucoma or ocular hypertension. Br J Ophthalmol (2009) 0.91
Active prevention in diabetic eye disease. A 4-year follow-up. Acta Ophthalmol Scand (1997) 0.91
Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs. Pharmazie (2004) 0.88
Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand (1999) 0.88
Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms. Pharm Res (1998) 0.87
Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations. Pharmazie (2008) 0.87
Effects of retrobulbar bupivacaine on post-operative pain and nausea in retinal detachment surgery. Acta Ophthalmol (Copenh) (1993) 0.86
Quantitative measurements of retinal edema by specific gravity determinations. Invest Ophthalmol Vis Sci (1987) 0.86
In vivo O2 consumption in rhesus monkeys in light and dark. Exp Eye Res (1983) 0.85
Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest Ophthalmol Vis Sci (1996) 0.85
The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie (2002) 0.85
Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy. Am J Ophthalmol (1988) 0.84
Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin. Pharm Res (1991) 0.83
Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro. Acta Pharm Nord (1989) 0.82
Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol. Acta Pharm Nord (1989) 0.81
Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal antiinflammatory agents. Pharm Res (1999) 0.81
Stabilizing effect of tris(hydroxymethyl)aminomethane on N-nitrosoureas in aqueous solutions. J Pharm Sci (1992) 0.80
Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J Pharm Pharmacol (1994) 0.80
Aqueous hydrocortisone mouthwash solution: clinical evaluation. Acta Odontol Scand (1998) 0.79
Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution. Int J Pharm (1999) 0.79
Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. J Pharm Sci (1988) 0.79
Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. J Pharm Sci (1995) 0.78
Dermal delivery of ETH-615, a zwitterionic drug. Drug Dev Ind Pharm (2000) 0.78
Soft antibacterial agents. Curr Med Chem (2003) 0.78
Studies on curcumin and curcuminoids. XLVI. Photophysical properties of dimethoxycurcumin and bis-dehydroxycurcumin. J Fluoresc (2011) 0.77
Marine lipids for prodrugs, soft compounds and other pharmaceutical applications. Pharmazie (2000) 0.77
Optic nerve oxygen tension: the effects of timolol and dorzolamide. Br J Ophthalmol (2004) 0.77
Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev Ind Pharm (1998) 0.77
Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets. Pharmazie (1996) 0.77
Intraocular pressure effects on optic nerve-head oxidative metabolism measured in vivo. Graefes Arch Clin Exp Ophthalmol (1990) 0.77
Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. Invest Ophthalmol Vis Sci (2000) 0.77
Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie (2006) 0.77
Prevention of diabetic blindness. Br J Ophthalmol (2006) 0.76
Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2. Pharm Res (1984) 0.76
Diabetic maculopathy. Acta Ophthalmol Scand (1999) 0.75
Indomethacin lowers optic nerve oxygen tension and reduces the effect of carbonic anhydrase inhibition and carbon dioxide breathing. Br J Ophthalmol (2004) 0.75
Exudative retinal detachment in familial pulmonary hypertension. Acta Ophthalmol (Copenh) (1991) 0.75
Capillary endothelial-cell mitogenic activity in experimental branch vein occlusion. Graefes Arch Clin Exp Ophthalmol (1990) 0.75
Trifluorothymidine: potential non-invasive diagnosis of herpes simplex infection using 19F nuclear magnetic resonance in a murine hepatitis model. J Virol Methods (1987) 0.75
Topical delivery of acetazolamide for psoriasis. Acta Derm Venereol (1993) 0.75
Effect of cyclodextrins on the degradation rate of benzylpenicillin. Pharmazie (2016) 0.75
The effect of phosphine oxides on transdermal delivery. Acta Pharm Nord (1990) 0.75
Solubility and permeability of steroids in water in the presence of potassium halides. Pharmazie (2010) 0.75
Effect of oleic acid on diffusion of drugs through hairless mouse skin. Acta Pharm Nord (1989) 0.75
Release of anti-inflammatory drugs from a silicone elastomer matrix system. Pharmazie (2009) 0.75
Indomethacin decreases optic nerve oxygen tension by a mechanism other than cyclo-oxygenase inhibition. Br J Ophthalmol (2007) 0.75
Improved delivery through biological membranes XD: Percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxybenzoate and related aspirin prodrugs. J Pharm Sci (1981) 0.75
Marine lipids as building blocks for soft quaternary ammonium compounds and their antibacterial activity. Pharmazie (2004) 0.75
Peptide dot immunoassay and immunoblotting: electroblotting from aluminum thin-layer chromatography plates and isoelectric focusing gels to activated nitrocellulose. Electrophoresis (1993) 0.75
Lipophilic metronidazole derivatives and their absorption through hairless mouse skin. Pharmazie (2000) 0.75
Improved delivery through biological membranes. XLV. Synthesis, physical-chemical evaluation, and brain uptake studies of 2-chloroethyl nitrosourea delivery systems. Pharm Res (1992) 0.75
Investigation of soft long chain quaternary ammonium compounds as co-factors to enhance in vitro gene delivery. Pharmazie (2006) 0.75
Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Pharmazie (1998) 0.75
Biconcave contact lens for examination and laser treatment of the fundus in normal and gas-filled phakic eyes. Am J Ophthalmol (1984) 0.75
Improved delivery through biological membranes VIII: Design, synthesis, and in vivo testing of true prodrugs of aspirin. J Pharm Sci (1981) 0.75
Novel central nervous system targeted semisynthetic penicillins. Drug Des Deliv (1990) 0.75
Pharmacy in Iceland. Ann Pharmacother (1994) 0.75
Effect of various marine lipids on transdermal drug delivery--in vitro evaluation. Boll Chim Farm (1997) 0.75
Sustained drug delivery system based on a cationic polymer and an anionic drug/cyclodextrin complex. Pharmazie (2001) 0.75
Improved delivery through biological membranes IX: Kinetics and mechanism of hydrolysis of methylsulfinymethyl 2-acetoxybenzoate and related aspirin prodrugs. J Pharm Sci (1981) 0.75
The effect of ionization on partition coefficients and topical delivery. Acta Pharm Suec (1985) 0.75